Novo Nordisk A/S ADR
(NVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,508,510 | 14,643,260 | 12,150,770 | 7,862,340 | 7,598,139 |
| Depreciation Amortization | 3,328,075 | 2,770,515 | 1,366,768 | 1,042,459 | 958,578 |
| Accounts receivable | 165,480 | -1,040,955 | -2,063,292 | -1,404,247 | -2,053,822 |
| Accounts payable and accrued liabilities | 396,365 | 469,800 | 1,454,759 | 951,127 | 501,642 |
| Other Working Capital | 386,676 | 1,492,340 | 2,903,710 | -755,578 | -1,377,170 |
| Other Operating Activity | -1,753,066 | -794,600 | 725 | 3,474,298 | 3,123,133 |
| Operating Cash Flow | $18,032,040 | $17,540,360 | $15,813,440 | $11,170,400 | $8,750,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,536,104 | 777,635 | -690,862 | -413,614 | 186,465 |
| PPE Investments | -9,105,196 | -6,838,780 | -3,747,031 | -1,719,874 | -1,007,898 |
| Net Acquisitions | 152,006 | -11,913,630 | N/A | -1,001,820 | -2,908,825 |
| Purchase Of Investment | -34,065 | -113,970 | -39,349 | -23,930 | -1,131,678 |
| Sale Of Investment | 4,542 | N/A | 4,792 | N/A | N/A |
| Purchase Sale Intangibles | -4,537,912 | -601,025 | -1,900,668 | -369,151 | -167,055 |
| Other Investing Activity | -4,537,911 | -601,035 | -1,900,668 | -369,151 | -166,419 |
| Investing Cash Flow | $-11,984,520 | $-18,689,780 | $-6,373,118 | $-3,528,389 | $-5,028,355 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,735,150 | 11,511,700 | N/A | 1,588,044 | 3,525,656 |
| Debt Repayment | -11,989,060 | -918,575 | -213,008 | -1,929,017 | -1,064,220 |
| Common Stock Repurchased | -210,143 | -2,926,245 | -4,344,965 | -3,410,578 | -3,094,018 |
| Dividend Paid | -7,836,918 | -6,400,300 | -4,612,568 | -3,582,905 | -3,423,355 |
| Other Financing Activity | 0 | -5 | -1 | 1 | 1 |
| Financing Cash Flow | $-4,300,971 | $1,266,575 | $-9,170,542 | $-7,334,455 | $-4,055,936 |
| Exchange Rate Effect | -110,068 | 65,975 | -17,279 | -33,701 | 94,028 |
| Beginning Cash Position | 2,370,167 | 2,086,840 | 1,837,216 | 1,517,810 | 1,945,157 |
| End Cash Position | 4,006,650 | 2,269,975 | 2,089,719 | 1,791,665 | 1,705,393 |
| Net Cash Flow | $1,636,483 | $183,135 | $252,503 | $273,854 | $-239,764 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,032,040 | 17,540,360 | 15,813,440 | 11,170,400 | 8,750,500 |
| Capital Expenditure | -9,105,196 | -6,838,780 | -3,747,031 | -1,719,874 | -1,007,898 |
| Free Cash Flow | 8,926,844 | 10,701,580 | 12,066,409 | 9,450,526 | 7,742,602 |